ProfileGDS4718 / 1556571_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 13% 10% 10% 7% 14% 10% 14% 10% 19% 18% 15% 10% 16% 12% 7% 12% 14% 12% 8% 6% 11% 11% 11% 12% 11% 8% 12% 13% 12% 4% 6% 10% 9% 14% 13% 15% 9% 8% 10% 12% 16% 11% 10% 8% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.912613
GSM549102patient 115, normal, homogenized [OPG study]3.7845410
GSM549104patient 119, normal, homogenized [OPG study]3.7676310
GSM549108patient 138, normal, homogenized [OPG study]3.699567
GSM549119patient 077, normal, homogenized [OPG study]3.9230214
GSM549133patient 032, cancer, homogenized [OPG study]3.751410
GSM549139patient 042, cancer, homogenized [OPG study]3.9055914
GSM549099patient 107, normal, homogenized [OPG study]3.7905210
GSM549109patient 139, normal, homogenized [OPG study]4.1139519
GSM549110patient 046, normal, homogenized [OPG study]4.0719118
GSM549114patient 063, normal, homogenized [OPG study]3.9165515
GSM549122patient 082, normal, homogenized [OPG study]3.7936110
GSM549134patient 033, cancer, homogenized [OPG study]3.9781816
GSM549136patient 036, cancer, homogenized [OPG study]3.8210112
GSM549140patient 044, cancer, homogenized [OPG study]3.649977
GSM549111patient 047, normal, homogenized [OPG study]3.8345112
GSM549113patient 057, normal, homogenized [OPG study]3.8764514
GSM549132patient 031, cancer, homogenized [OPG study]3.8478312
GSM549137patient 038, cancer, homogenized [OPG study]3.682898
GSM549142patient 047, cancer, homogenized [OPG study]3.687326
GSM549100patient 110, normal, homogenized [OPG study]3.8124411
GSM549107patient 135, normal, homogenized [OPG study]3.7923311
GSM549115patient 068, normal, homogenized [OPG study]3.7975211
GSM549116patient 072, normal, homogenized [OPG study]3.8528512
GSM549120patient 078, normal, homogenized [OPG study]3.8038611
GSM549131patient 030, cancer, homogenized [OPG study]3.683218
GSM549118patient 074, normal, homogenized [OPG study]3.8614312
GSM549129patient 027, cancer, homogenized [OPG study]3.8908413
GSM549123patient 088, normal, homogenized [OPG study]3.8601612
GSM549124patient 006, cancer, homogenized [OPG study]3.577094
GSM549126patient 015, cancer, homogenized [OPG study]3.615896
GSM549128patient 025, cancer, homogenized [OPG study]3.7428510
GSM549103patient 117, normal, homogenized [OPG study]3.775719
GSM549117patient 073, normal, homogenized [OPG study]3.9138114
GSM549138patient 041, cancer, homogenized [OPG study]3.8861113
GSM549141patient 045, cancer, homogenized [OPG study]3.9076915
GSM549130patient 028, cancer, homogenized [OPG study]3.744879
GSM549101patient 111, normal, homogenized [OPG study]3.685278
GSM549105patient 128, normal, homogenized [OPG study]3.8013210
GSM549106patient 134, normal, homogenized [OPG study]3.8173812
GSM549112patient 048, normal, homogenized [OPG study]4.0084716
GSM549125patient 011, cancer, homogenized [OPG study]3.8315511
GSM549127patient 024, cancer, homogenized [OPG study]3.7671210
GSM549135patient 035, cancer, homogenized [OPG study]3.674298